Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives

author
created [InstanceEdit:9931616] Shamovsky, Veronica, 2024-12-12
dbId 9931619
displayName Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives
journal J Blood Med
pages 191-199
pubMedIdentifier 35465188
schemaClass LiteratureReference
title Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives
url http://www.ncbi.nlm.nih.gov/pubmed/35465188
volume 13
year 2022
Cite Us!